U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Assay Migration Studies for In Vitro Diagnostic Devices
  1. Regulatory Information

GUIDANCE DOCUMENT

Assay Migration Studies for In Vitro Diagnostic Devices Guidance for Industry and FDA Staff April 2013

Final

Assay Migration Studies for In Vitro Diagnostic Devices

Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health

This guidance outlines FDA’s regulatory approach for approval of Class III in vitro diagnostic devices, as well as certain licensed or certain cleared in vitro diagnostic devices in cases, when a previously approved, licensed, or cleared assay is migrating (i.e., transitioning) to another system for which assay performance has not been evaluated by FDA. In this guidance the term “new system” refers to the system (assay, instrument, and software) to which the assay is migrating from a previously approved/licensed/cleared system. The term “old system” refers to the system (assay, instrument and software) which was approved/licensed/cleared from which the assay is migrating to a currently unapproved/unlicensed/uncleared system.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.